• 2mg, 5mg tablets – 10mg tablets should no longer be used.
• 2mg in 5ml oral solution.
• 10mg in 2ml injection (plain & emulsion) .
  
  • For use in epilepsy see section 4.8.2 and use in anxiety see
    section 4.1.2.
  
  

• See section 04.01.02.

• 5mg in 5ml, 10mg in 2ml injections
• 50mg in 50ml prefilled syringes - ITU use only 
• Intranasal midazolam 40mg/ml + lidocaine 20mg/ml 
  
  • approved for use prior to cannulation for adult patients with
    special needs receiving dental treatment under IV sedation.

• Miprosed® 5mg in 1ml (7.5ml) oral solution is approved for use as a sedative and pre-medication in children 

Palliative care

• 10mg/2ml injection 

• see section 04.01.01

• 30mg/5ml syrup.
  
  • see section 03.04.01 for other formulations.